143 related articles for article (PubMed ID: 28505475)
1. Colorectal cancer subtypes: Translation to routine clinical pathology.
Roseweir AK; McMillan DC; Horgan PG; Edwards J
Cancer Treat Rev; 2017 Jun; 57():1-7. PubMed ID: 28505475
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
4. Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.
Bramsen JB; Rasmussen MH; Ongen H; Mattesen TB; Ørntoft MW; Árnadóttir SS; Sandoval J; Laguna T; Vang S; Øster B; Lamy P; Madsen MR; Laurberg S; Esteller M; Dermitzakis ET; Ørntoft TF; Andersen CL
Cell Rep; 2017 May; 19(6):1268-1280. PubMed ID: 28494874
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.
Fessler E; Medema JP
Trends Cancer; 2016 Sep; 2(9):505-518. PubMed ID: 28741479
[TBL] [Abstract][Full Text] [Related]
7. RNA biomarkers in colorectal cancer.
Bustin SA; Murphy J
Methods; 2013 Jan; 59(1):116-25. PubMed ID: 23079397
[TBL] [Abstract][Full Text] [Related]
8. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
[TBL] [Abstract][Full Text] [Related]
9. Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.
Fontana E; Eason K; Cervantes A; Salazar R; Sadanandam A
Ann Oncol; 2019 Apr; 30(4):520-527. PubMed ID: 30796810
[TBL] [Abstract][Full Text] [Related]
10. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
[TBL] [Abstract][Full Text] [Related]
11. Back to the Colorectal Cancer Consensus Molecular Subtype Future.
Menter DG; Davis JS; Broom BM; Overman MJ; Morris J; Kopetz S
Curr Gastroenterol Rep; 2019 Jan; 21(2):5. PubMed ID: 30701321
[TBL] [Abstract][Full Text] [Related]
12. Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content.
Miller SA; Ghobashi AH; O'Hagan HM
Cancer Genet; 2021 Jun; 254-255():34-39. PubMed ID: 33571895
[TBL] [Abstract][Full Text] [Related]
13. Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.
Sadanandam A; Wang X; de Sousa E Melo F; Gray JW; Vermeulen L; Hanahan D; Medema JP
Cell Cycle; 2014; 13(3):353-7. PubMed ID: 24406433
[TBL] [Abstract][Full Text] [Related]
14. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
Dreyer C; Afchain P; Trouilloud I; André T
Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450
[TBL] [Abstract][Full Text] [Related]
15. Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.
Sinicrope FA; Okamoto K; Kasi PM; Kawakami H
Clin Gastroenterol Hepatol; 2016 May; 14(5):651-8. PubMed ID: 26872400
[TBL] [Abstract][Full Text] [Related]
16. Differential expression patterns of the insulin-like growth factor 2 gene in human colorectal cancer.
Li SR; Ng CF; Banerjea A; Ahmed S; Hands R; Powar M; Ogunkolade W; Dorudi S; Bustin SA
Tumour Biol; 2004; 25(1-2):62-8. PubMed ID: 15192314
[TBL] [Abstract][Full Text] [Related]
17. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.
Sideris M; Papagrigoriadis S
Anticancer Res; 2014 May; 34(5):2061-8. PubMed ID: 24778007
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma.
Kim JW; Shin MK; Kim BC
J Korean Med Sci; 2015 Jan; 30(1):16-23. PubMed ID: 25552879
[TBL] [Abstract][Full Text] [Related]
20. Early-onset colorectal cancer: a separate subset of colorectal cancer.
Silla IO; Rueda D; Rodríguez Y; García JL; de la Cruz Vigo F; Perea J
World J Gastroenterol; 2014 Dec; 20(46):17288-96. PubMed ID: 25516639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
